Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 327 followers

Latest posts

Last updated about 9 hours ago

Novo’s CagriSema tops semaglutide in ph. 3 diabetes study

about 9 hours ago

Novo Nordisk’s GLP-1/amylin combo has topped blockbuster semaglutide in a phase 3...

GSK plans to lay off up to 350 R&D workers across US, UK

about 10 hours ago

GSK is trimming its R&D team, a move that is expected to...

Thermo Fisher trims Massachusetts headcount with Franklin site closure

about 11 hours ago

Thermo Fisher is continuing its recent layoff spree with a fresh round...

GSK gives back rights to Wave's genetic disease RNA editor

about 13 hours ago

Wave Life Sciences has the fate of its lead RNA editing candidate...

Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again

about 14 hours ago

Daiichi Sankyo’s development of ADCs continues to hit turbulence. The company has...

China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug

about 14 hours ago

Having already secured regional rights to vTv Therapeutics’ inflammation drug, China’s Newsoara...

Skye links CB1-Wegovy combo to 22.3% weight loss after a year in extension of failed ph. 2 study

about 15 hours ago

Skye Bioscience has published 52-week data on its investigational obesity drug combination...

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

about 16 hours ago

Optellum, a 2016 spinout from the University of Oxford, has been tapped...

Roche's return to RNA continues with $1.7B deal for Sanegene program

about 16 hours ago

Roche is continuing its return to the RNAi space by paying $200...

Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health

about 16 hours ago

As biotech and other sectors of the life sciences industry espouse cautious...

A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders

about 16 hours ago

Staar Surgical has endured a whirlwind start to the New Year with...

AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection

about 18 hours ago

Nine in 10 people worldwide have been infected with Epstein-Barr virus. But...